{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:11:04Z","timestamp":1761419464114,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.sleep.2021.03.039","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T02:38:38Z","timestamp":1617935918000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1980-5728","authenticated-orcid":false,"given":"Sebastiano","family":"Cicco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Castellana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Di Lecce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Carrat\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Prete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onofrio","family":"Resta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna Elisiana","family":"Carpagnano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Dragonieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.sleep.2021.03.039_bib1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.sleep.2021.03.039_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacc.2016.11.069","article-title":"Sleep apnea: types, mechanisms, and clinical cardiovascular consequences","volume":"69","author":"Javaheri","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sleep.2021.03.039_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s11325-019-01945-w","article-title":"Obstructive sleep apnea and cardiovascular disease, a story of confounders!","author":"Collen","year":"2020","journal-title":"Sleep Breath"},{"issue":"2","key":"10.1016\/j.sleep.2021.03.039_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-020-1257-y","article-title":"Obstructive sleep apnea, hypertension, and cardiovascular risk: epidemiology, pathophysiology, and management","volume":"22","author":"Salman","year":"2020","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"10.1016\/j.sleep.2021.03.039_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4081\/monaldi.2017.822","article-title":"Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome","volume":"87","author":"Devito","year":"2017","journal-title":"Monaldi Arch Chest Dis"},{"issue":"4","key":"10.1016\/j.sleep.2021.03.039_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.0000136587.68725.8E","article-title":"Association of atrial fibrillation and obstructive sleep apnea","volume":"110","author":"Gami","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.sleep.2021.03.039_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0735-1097(03)00184-0","article-title":"Obstructive sleep apnea and cardiovascular disease","volume":"41","author":"Lattimore","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.sleep.2021.03.039_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","article-title":"Sleep-disordered breathing and cardiovascular disease","volume":"163","author":"Shahar","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.sleep.2021.03.039_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrcardio.2010.145","article-title":"Mechanisms of vascular damage in obstructive sleep apnea","volume":"7","author":"Kohler","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.sleep.2021.03.039_bib10","first-page":"631","article-title":"Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?","volume":"64","author":"Ryan","year":"2009","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.sleep.2021.03.039_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.5664\/jcsm.3070","article-title":"Serum inflammatory markers in obstructive sleep apnea: a meta-analysis","volume":"9","author":"Nadeem","year":"2013","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"17","key":"10.1016\/j.sleep.2021.03.039_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94379","article-title":"Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea","volume":"2","author":"Perrini","year":"2017","journal-title":"JCI insight"},{"issue":"33","key":"10.1016\/j.sleep.2021.03.039_bib13","doi-asserted-by":"crossref","first-page":"20807","DOI":"10.1016\/S0021-9258(17)31891-4","article-title":"Galectins. Structure and function of a large family of animal lectins","volume":"269","author":"Barondes","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.sleep.2021.03.039_bib14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/molbev\/msh082","article-title":"Phylogenetic analysis of the vertebrate galectin family","volume":"21","author":"Houzelstein","year":"2004","journal-title":"Mol Biol Evol"},{"issue":"1","key":"10.1016\/j.sleep.2021.03.039_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.sleep.2021.03.039_bib16","first-page":"599","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)","volume":"41","author":"Dong","year":"2018","journal-title":"Int J Mol Med"},{"issue":"19","key":"10.1016\/j.sleep.2021.03.039_bib17","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.sleep.2021.03.039_bib18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.sleep.2021.03.039_bib19","first-page":"344","article-title":"Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function","volume":"16","author":"Yakar T\u00fcl\u00fcce","year":"2016","journal-title":"Anatol J Cardiol"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2021.03.039_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2009.09.001","article-title":"The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients","volume":"409","author":"Lin","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.sleep.2021.03.039_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis,in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"10.1016\/j.sleep.2021.03.039_bib22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"De Boer","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.sleep.2021.03.039_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jch.12757","article-title":"Galectin-3 predicts left ventricular remodeling of hypertension","volume":"18","author":"Yao","year":"2016","journal-title":"J\u00a0Clin Hypertens"},{"issue":"3","key":"10.1016\/j.sleep.2021.03.039_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.sleep.2021.03.039_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/erc.12.159","article-title":"Neutrophil to lymphocyte ratio and cardiovascular diseases: a review","volume":"11","author":"Bhat","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9","key":"10.1016\/j.sleep.2021.03.039_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1017\/S0022215115001747","article-title":"Investigation of the relationship between neutrophil-to-lymphocyte ratio and obstructive sleep apnoea syndrome","volume":"129","author":"Yenigun","year":"2015","journal-title":"J\u00a0Laryngol Otol"},{"issue":"3","key":"10.1016\/j.sleep.2021.03.039_bib27","first-page":"295","article-title":"The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea","volume":"67","author":"Oyama","year":"2016","journal-title":"J\u00a0Cardiol"},{"issue":"17","key":"10.1016\/j.sleep.2021.03.039_bib28","first-page":"3234","article-title":"Neutrophil-to-lymphocyte ratio in obstructive sleep apnea; a multi center, retrospective study","volume":"19","author":"Altintas","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.sleep.2021.03.039_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.hrtlng.2016.01.002","article-title":"The neutrophil-to-lymphocyte ratio in patients with obstructive sleep apnoea syndrome and its relationship with cardiovascular disease","volume":"45","author":"Uygur","year":"2016","journal-title":"Hear Lung J Acute Crit Care"},{"key":"10.1016\/j.sleep.2021.03.039_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-91287-5_40","article-title":"Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: preliminary results","volume":"1072","author":"Cicco","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.sleep.2021.03.039_bib31","first-page":"PA2548","article-title":"Elevated levels of BMI positively correlate with increased cardiovascular risk in patients with Obstructive Sleep Apnea","volume":"52","author":"Carrat\u00f9","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.sleep.2021.03.039_bib32","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.chest.2016.08.1469","article-title":"Does nocturnal hypoventilation have a protective effect on cardiovascular comorbidity in obesity hypoventilation syndrome?","volume":"150","author":"Castellana","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.sleep.2021.03.039_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/rej.2017.2030","article-title":"Nocturnal hypoventilation may have a protective effect on ischemic heart disease in patients with obesity hypoventilation syndrome","volume":"22","author":"Castellana","year":"2019","journal-title":"Rejuvenation Res"},{"issue":"1","key":"10.1016\/j.sleep.2021.03.039_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10238-019-00600-8","article-title":"Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease","volume":"20","author":"Leone","year":"2020","journal-title":"Clin Exp Med"},{"issue":"9","key":"10.1016\/j.sleep.2021.03.039_bib35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.sleep.2021.03.039_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","author":"Ho","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.sleep.2021.03.039_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep34357","article-title":"Serum galectin-3 levels predict recurrences after ablation of atrial fibrillation","volume":"6","author":"Clementy","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.sleep.2021.03.039_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2014.10.009","article-title":"Galectin-3 and heart failure: prognosis, prediction & clinical utility","volume":"443","author":"Filipe","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.sleep.2021.03.039_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.sleep.2021.03.039_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1586\/14779072.2016.1154788","article-title":"Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update","volume":"14","author":"Afari","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"11","key":"10.1016\/j.sleep.2021.03.039_bib41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4149\/BLL_2015_125","article-title":"The association of neutrophil to\u00a0lymphocyte ratio with presence and severity of obstructive sleep apnea","volume":"116","author":"Sunbul","year":"2015","journal-title":"Bratisl Med J"},{"issue":"5","key":"10.1016\/j.sleep.2021.03.039_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/glycob\/cwi026","article-title":"Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways","volume":"15","author":"Fern\u00e1ndez","year":"2005","journal-title":"Glycobiology"},{"issue":"6","key":"10.1016\/j.sleep.2021.03.039_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4906(02)02232-9","article-title":"Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?","volume":"23","author":"Rabinovich","year":"2002","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.sleep.2021.03.039_bib44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/ATVBAHA.114.304964","article-title":"Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease","volume":"35","author":"Maiolino","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.sleep.2021.03.039_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5603\/KP.a2016.0185","article-title":"Galectin-3 is associated with coronary plaque burden and obstructive sleep apnoea syndrome severity","volume":"75","author":"Pusuroglu","year":"2017","journal-title":"Kardiol Pol"},{"issue":"2","key":"10.1016\/j.sleep.2021.03.039_bib46","first-page":"85","article-title":"Biomarkers \u2013 a possibility for monitoring of obstructive sleep apnea syndrome","volume":"40","author":"Slouka","year":"2019","journal-title":"Neuroendocrinol Lett"},{"issue":"2","key":"10.1016\/j.sleep.2021.03.039_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5664\/jcsm.8176","article-title":"Treatment of obstructive sleep apnea with CPAP improves chronic inflammation measured by neutrophil-to-lymphocyte ratio","volume":"16","author":"Al-Halawani","year":"2020","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2021.03.039_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5578\/tt.66535","article-title":"Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity?","volume":"66","author":"Bozku\u015f","year":"2018","journal-title":"Tuberk Toraks"},{"issue":"1","key":"10.1016\/j.sleep.2021.03.039_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67708-w","article-title":"Association between the neutrophil-to-lymphocyte ratio and obstructive sleep apnea: a meta-analysis","volume":"10","author":"Rha","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.sleep.2021.03.039_bib50","first-page":"1","article-title":"Prognostic association of routinely measured biomarkers in patients admitted to critical care: a systematic review","volume":"9","author":"Wan","year":"2020","journal-title":"Biomarkers"},{"key":"10.1016\/j.sleep.2021.03.039_bib51","article-title":"Galactin-3 and soluble ST2 as complementary tools to cardiac MRI for sudden cardiac death risk stratification in heart failure: a review","volume":"9","author":"Shah","year":"2020","journal-title":"JRSM Cardiovasc Dis"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945721002100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945721002100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:30:44Z","timestamp":1761406244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945721002100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":51,"alternative-id":["S1389945721002100"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2021.03.039","relation":{},"ISSN":["1389-9457"],"issn-type":[{"type":"print","value":"1389-9457"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2021.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}